LMNL
$5.45
Liminal Biosciences
$.44
8.78%
LMNL
Earnings Whisper ®
N/A
4th Quarter December 2022
Consensus:  $0.00
Revenue:  N/A
Wednesday
Feb 15
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LMNL reports earnings?
Beat
Meet
Miss

Where is LMNL's stock price going from here?
Up
Flat
Down
Stock chart of LMNL
Analysts
Summary of analysts' recommendations for LMNL
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Liminal BioSciences Inc. is a biotechnology company. It engages in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. The company's product pipeline consists of PBI-4050, which are in clinical stage. Liminal BioSciences Inc., formerly known as Prometic Life Sciences Inc., is based in Laval, Canada.